Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-23-016774
Filing Date
2023-06-06
Accepted
2023-06-06 17:21:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 vxrt20230606_424b5.htm 424B5 440169
2 logo01.jpg GRAPHIC 17930
3 logo.jpg GRAPHIC 10084
  Complete submission text file 0001437749-23-016774.txt   480264
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-270671 | Film No.: 23997038
SIC: 2836 Biological Products, (No Diagnostic Substances)